MCCULLOCH KEVIN (See Remarks) sold 5.1% of their position (90K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $722.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0002031695-26-000008
Officer· See Remarks
Since Mar 2026
-90K
Net shares
Net seller
$722.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
90K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−90K
Price / share
$8.03
Trade value
$722.51K
% of position
5.1%
7/1/2026
1.78M→1.69M
Total
Net shares
−90K
Net value
-$722.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | S · Sale | −90K | $8.03 | $722.51K | 5.1% | 1.78M | 1.69M |
| Total | −90K | -$722.51K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned25K
Total
25K indirect25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Total | 25K | 25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported